Inventor · disambiguated record
Gregory A. Mcclelland
Also filed as: MCCLELLAND GREGORY A
9 granted patents·4 pending applications·1,998 citations·filing 1988–2024
90Inventor score
Top patents by PatentIndex Score
13 records- 0198US5120548ASwelling modulated polymeric drug delivery deviceMERCK & CO INC·Filed 1989·Granted Jun 9, 1992·1.7k cites·6 claims
- 0295US11311532B2High dosage valbenazine formulation and compositions, methods, and kits related theretoNEUROCRINE BIOSCIENCES INC·Filed 2020·Granted Apr 26, 2022·3 cites·32 claims
- 0391US11026939B2High dosage valbenazine formulation and compositions, methods, and kits related theretoNEUROCRINE BIOSCIENCES INC·Filed 2020·Granted Jun 8, 2021·5 cites·29 claims
- 0486US4994273ASolubility modulated drug delivery deviceMERCK & CO INC·Filed 1989·Granted Feb 19, 1991·84 cites·18 claims
- 0583US5350584ASpheronization process using charged resinsMERCK & CO INC·Filed 1992·Granted Sep 27, 1994·72 cites·13 claims
- 0680US4946686ASolubility modulated drug delivery systemMERCK & CO INC·Filed 1989·Granted Aug 7, 1990·61 cites·8 claims
- 0768US12102637B2Pharmaceutical formulations for treating endometriosis, uterine fibroids, polycystic ovary syndrome or adenomyosisABBVIE INC·Filed 2023·Granted Oct 1, 2024·0 cites·16 claims
- 0868US2025000862A1Pharmaceutical formulations for treating endometriosis, uterine fibroids, polycystic ovary syndrome or adenomyosisABBVIE INC·Filed 2024·Application pending·0 cites
- 0965US2020276184A1High Dosage Valbenazine Formulation and Compositions, Methods, and Kits Related TheretoNEUROCRINE BIOSCIENCES INC·Filed 2018·Application pending·0 cites
- 1061US4976967AResin modulated drug delivery device for the delivery of HMG-CoA reductase inhibitor saltsMERCK & CO INC·Filed 1988·Granted Dec 11, 1990·26 cites·17 claims
- 1155US2025213486A1Solid Pharmaceutical Formulations for Treating Endometriosis, Uterine Fibroids, Polycystic Ovary Syndrome or AdenomyosisABBVIE INC·Filed 2024·Application pending·0 cites
- 1242US12083227B2Solid pharmaceutical formulations for treating endometriosis, uterine fibroids, polycystic ovary syndrome or adenomyosisABBVIE INC·Filed 2018·Granted Sep 10, 2024·0 cites·46 claims
- 1339US2019054088A1Pharmaceutical Formulations for Treating Endometriosis, Uterine Fibroids, Polycystic Ovary Syndrome or AdenomyosisABBVIE INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Gregory A. Mcclelland files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →